histidine has been researched along with Paraganglioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamski, J; Beuschlein, F; Deutschbein, T; Eisenhofer, G; Erlic, Z; Fassnacht, M; Januszewicz, A; Kroiss, M; Kurlbaum, M; Nölting, S; Prehn, C; Prejbisz, A; Reincke, M; Richter, S; Robledo, M; Timmers, H; Weismann, D | 1 |
| Baysal, BE; Deb, A; Young, AL; Young, WF | 1 |
2 other study(ies) available for histidine and Paraganglioma
| Article | Year |
|---|---|
Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removal.
Topics: Adolescent; Adult; Aged; Catecholamines; Chromatography, Liquid; Creatinine; Female; Histidine; Humans; Male; Metabolomics; Middle Aged; Ornithine; Paraganglioma; Pheochromocytoma; Prospective Studies; Sarcosine; Tandem Mass Spectrometry; Tyrosine; Young Adult | 2019 |
Familial malignant catecholamine-secreting paraganglioma with prolonged survival associated with mutation in the succinate dehydrogenase B gene.
Topics: Adult; Amino Acid Substitution; Arginine; Bone Neoplasms; Catecholamines; Conserved Sequence; Exons; Histidine; Humans; Male; Multiple Endocrine Neoplasia Type 2a; Mutation, Missense; Paraganglioma; Point Mutation; Succinate Dehydrogenase | 2002 |